|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.930 USD | -1.82% |
|
-6.91% | +48.99% |
| Market Cap | 88.85M 77.72M 71.68M 66.21M 126M 8.47B 128M 856M 336M 4.17B 334M 326M 14.35B | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 87.59M 76.61M 70.66M 65.27M 124M 8.35B 126M 844M 332M 4.12B 329M 322M 14.15B | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.09% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cumberland Pharmaceuticals Inc.
| 1 day | -1.82% | ||
| 1 week | -6.91% | ||
| Current month | -8.49% | ||
| 1 month | +4.59% | ||
| 3 months | +91.91% | ||
| 6 months | +19.80% | ||
| Current year | +48.99% |
| 1 week | 5.76 |  | 6.75 |
| 1 month | 5.44 | | 7.36 |
| Current year | 2.69 | | 7.36 |
| 1 year | 1.85 | | 7.36 |
| 3 years | 1.04 | | 7.36 |
| 5 years | 1.04 | | 7.51 |
| 10 years | 0 | | 7.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 1999-01-06 |
John Hamm
DFI | Director of Finance/CFO | 70 | 2021-05-16 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 1999-01-06 |
| Director/Board Member | 74 | 2010-09-09 | |
James Jones
BRD | Director/Board Member | 78 | 2009-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-17 | Free | Director | 1,800 | 0.0120% | ||
| 03-17 | Free | Chief Executive Officer | 100,000 | 0.6686% | ||
| 03-17 | Free | Responsable ventes & marketing | 3,000 | 0.0201% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.82% | -6.91% | +97.67% | +314.69% | 88.85M | |
| -2.33% | -2.09% | +49.88% | +170.51% | 1,060B | |
| -0.82% | -2.30% | +63.79% | +62.00% | 619B | |
| -0.73% | -4.98% | +28.91% | +82.99% | 438B | |
| +0.33% | -1.17% | +31.07% | +27.09% | 333B | |
| -0.02% | -2.85% | +29.15% | +45.24% | 282B | |
| -3.89% | -11.22% | +22.81% | +27.30% | 267B | |
| +0.66% | -1.42% | -26.59% | -37.71% | 218B | |
| -0.06% | -2.88% | +23.07% | +62.33% | 196B | |
| -3.72% | -1.10% | +18.41% | +70.56% | 161B | |
| Average | -1.24% | -3.61% | +33.82% | +82.50% | 357.4B | |
| Weighted average by Cap. | -1.31% | -2.96% | +36.75% | +83.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 37.87M 33.12M 30.55M 28.22M 53.54M 3.61B 54.44M 365M 143M 1.78B 142M 139M 6.12B | 44.52M 38.94M 35.92M 33.18M 62.95M 4.25B 64.01M 429M 169M 2.09B 167M 164M 7.19B |
| Net income | -6.48M -5.67M -5.23M -4.83M -9.16M -618M -9.32M -62.46M -24.53M -304M -24.33M -23.8M -1.05B | -2.84M -2.48M -2.29M -2.11M -4.01M -270M -4.08M -27.34M -10.74M -133M -10.65M -10.42M -458M |
| Net Debt | 2.61M 2.28M 2.1M 1.94M 3.69M 249M 3.75M 25.14M 9.87M 123M 9.79M 9.58M 421M | -1.26M -1.11M -1.02M -942K -1.79M -121M -1.82M -12.19M -4.79M -59.4M -4.75M -4.64M -204M |
Employees
93
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | US$5.930 | -1.82% | 48,632 |
| 26-07-09 | US$6.040 | -3.36% | 30,326 |
| 26-07-08 | US$6.250 | -0.64% | 41,098 |
| 26-07-07 | US$6.290 | +2.11% | 32,056 |
| 26-07-06 | US$6.160 | -3.30% | 46,871 |
- Stock Market
- Stocks
- CPIX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
